BSEGeneral13 Sept 2026 · 13 Sept 2026, 04:27 pm
Outcome of Board Meeting
Gland Pharma Ltd · 543245
✦ AI Summary▲ PositiveM&A
Gland Pharma Ltd has informed that its Board of Directors has approved the acquisition of 100% equity share capital of Gland Pharma USA Inc. from Gland Pharma International Pte. Ltd, a wholly-owned subsidiary of the Company. The acquisition is expected to be completed by October 31, 2026.
Analysis Scores
Earnings Impact6/10
Growth Catalyst8/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact7/10
Market Sentiment8/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gland Pharma Ltd - 543245 - Board Meeting Outcome for Outcome Of Board Meeting